pAdlox [66]. GFP control adenoviral vector was generated by the sub-cloning of the eGFP cDNA into the pAdlox vector. Recombinant adenoviral particles, (hereafter termed RAd-m5T4, RAd-h5T4 and RAd-GFP) were generated by co-transfection of CRE8 cells with the pAdlox vector and adenovirus C5 DNA as described [66]. High-titre stocks were prepared by double cesium chloride density gradient separation and titred as previously described [63]. Viral stocks were found to be free of replication- competent adenovirus using a supernatant rescue assay using HeLa cells able to detect 1 replication-competent virus within 109 recombinant viruses [63]. A multiplicity of 30 infectious units per cell led to 100% of cells expressing m5T4 or h5T4 or GFP at 48 hours as assessed by FACS and when other biological assessments were made. References 1. Hole N, Stern PL (1988) A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer 57: 239–246. 2. Southall PJ, Boxer GM, Bagshawe KD, Hole N, Bromley M, et al. (1990) Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 61: 89–95. 3. Carsberg CJ, Myers KA, Evans GS, Allen TD, Stern PL (1995) Metastasis- associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci 108 (Pt8): 2905–2916. 4. Carsberg CJ, Myers KA, Stern PL (1996) Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer 68: 84–92. 5. Awan A, Lucic MR, Shaw DM, Sheppard F, Westwater C, et al. (2002) 5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis. Biochem Biophys Res Commun 290: 1030–1036. 6. Mulder WM, Stern PL, Stukart MJ, de Windt E, Butzelaar RM, et al. (1997) Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. Clin Cancer Res 3: 1923–1930. 7. Starzynska T, Marsh PJ, Schofield PF, Roberts SA, Myers KA, et al. (1994) Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br J Cancer 69: 899–902. 8. Starzynska T, Wiechowska-Kozlowska A, Marlicz K, Bromley M, Roberts SA, et al. (1998) 5T4 oncofetal antigen in gastric carcinoma and its clinical significance. Eur J Gastroenterol Hepatol 10: 479–484. 9. Wrigley E, McGown AT, Rennison J, Swindell R, Crowther D, et al. (1995) 5T4 oncofetal antigen expression in ovarian carcinoma. Int J Gynecol Cancer 5: 269–274. 10. King KW, Sheppard FC, Westwater C, Stern PL, Myers KA (1999) Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues. Biochim Biophys Acta 1445: 257–270. 11. Myers KA, Rahi-Saund V, Davison MD, Young JA, Cheater AJ, et al. (1994) Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem 269: 9319–9324. 12. Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition motif. Current Opinion in Structural Biology 11: 725–732. 13. Ward CM, Barrow K, Woods AM, Stern PL (2003) The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency. J Cell Sci 116: 4533–4542. 14. Ward CM, Eastham AM, Stern PL (2006) Cell surface 5T4 antigen is transiently upregulated during early human embryonic stem cell differentiation: effect of 5T4 phenotype on neural lineage formation. Exp Cell Res 312: 1713–1726. 15. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, et al. (2007) Epithelial- mesenchymal transition events during human embryonic stem cell differentia- tion. Cancer Res 67: 11254–11262. 16. Spencer HL, Eastham AM, Merry CL, Southgate TD, Perez-Campo F, et al. (2007) E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol Biol Cell 18: 2838–2851. 17. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118–132. 18. Smethurst G (2006) Microarray Analysis of Mouse ES Cell Differentiation Stratified by 5T4 Oncofoetal Antigen Expression. Manchestere: University of Manchester. 19. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, et al. (2002) A stem cell molecular signature. Science 298: 601–604. 20. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002) ‘‘Stemness’’: Transcriptional profiling of embryonic and adult stem cells. Science 298: 597–600. 5T4 Regulates CXCR4 Chemotaxis Statistical analysis Quoted errors refer to standard errors of the mean. Statistical significance was calculated by either two-tailed unpaired Student t- test or ANOVA test as appropriate. Acknowledgments Kate Mulryan and Steve Bagley for excellent research support and the PICR Biological Resource Unit and Molecular Core Facilities. Manuscript dedicated to Dr Veena Rahi (1964–2007). Author Contributions Conceived and designed the experiments: TDS OM FVC GJS CMW CJM PLS. Performed the experiments: TDS OM AJR MAM GM GJS DS. Analyzed the data: TDS OM FVC AJR MAM GM GJS DS CJM PLS. Contributed reagents/materials/analysis tools: TDS DS PLS. Wrote the paper: TDS OM FVC AJR PLS. 21. Christopherson KW, 2nd, Hangoc G, Mantel CR, Broxmeyer HE (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305: 1000–1003. 22. Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171–179. 23. Vandercappellen J, Van Damme J, Struyf S (2008) The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226–244. 24. Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761–1767. 25. Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul CC, et al. (1996) Molecular cloning and characterization of a murine pre-B-cell growth- stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci U S A 93: 14726–14729. 26. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, et al. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201–2213. 27. Marchese A (2006) Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members. Methods Mol Biol 327: 139–145. 28. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, et al. (1998) The alpha- chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G- protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273: 23169–23175. 29. Zhang J, Sarkar S, Yong VW (2005) The chemokine stromal cell derived factor- 1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloprotei- nase. Carcinogenesis 26: 2069–2077. 30. Marchese A, Raiborg C, Santini F, Keen JH, Stenmark H, et al. (2003) The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein- coupled receptor CXCR4. Dev Cell 5: 709–722. 31. Tarasova NI, Stauber RH, Michejda CJ (1998) Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J Biol Chem 273: 15883–15886. 32. Kim J, Chu J, Shen X, Wang J, Orkin SH (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049–1061. 33. Hall J, Guo G, Wray J, Eyres I, Nichols J, et al. (2009) Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 5: 597–609. 34. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4: 540–550. 35. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, et al. (2001) Amino- terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554–3561. 36. Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, et al. (2009) Hetero- oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of ‘‘selective’’ antagonists. J Biol Chem 284: 31270–31279. 37. Park BS, Song DH, Kim HM, Choi BS, Lee H, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191–1195. 38. Bhandari D, Trejo J, Benovic JL, Marchese A (2007) Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 282: 36971–36979. 39. Ding Y, Zhang L, Goodwin JS, Wang Z, Liu B, et al. (2008) Plectin regulates the signaling and trafficking of the HIV-1 co-receptor CXCR4 and plays a role in HIV-1 infection. Exp Cell Res 314: 590–602. 40. Luo C, Pan H, Mines M, Watson K, Zhang J, et al. (2006) CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis. J Biol Chem 281: 30081–30093. PLoS ONE | www.plosone.org 19 April 2010 | Volume 5 | Issue 4 | e9982